Literature DB >> 10494086

Attenuated familial adenomatous polyposis in a man with an interstitial deletion of chromosome arm 5q.

R T Pilarski1, A R Brothman, P Benn, S Shulman Rosengren.   

Abstract

Familial adenomatous polyposis (FAP) is an inherited colon cancer syndrome caused by mutations in the APC gene on chromosome region 5q21. Patients typically present with several hundred to several thousand polyps throughout the colon. Benign and malignant extracolonic manifestations are often present. Attenuated FAP (AFAP) is a recognized variant of FAP in which patients present with fewer than 100 polyps and appear to have a delayed onset of the clinical manifestations of FAP. Mutations in specific regions of the APC gene are associated with AFAP. A full deletion of the APC gene region has previously been thought to be associated with typical FAP. We now report on a 39-year-old man with a cytogenetically visible interstitial 5q deletion. Fluorescent in situ hybridization analysis with two cosmid probes specific for the 5' and 3' ends of the gene indicated that the entire APC locus is deleted. The number of polyps (50-60) seen in this patient was consistent with AFAP, as was the absence of multiple congenital hypertrophy of the retinal pigment epithelium (CHRPE). This is the first reported case of AFAP associated with a germline deletion of the entire APC gene. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10494086     DOI: 10.1002/(sici)1096-8628(19991008)86:4<321::aid-ajmg4>3.0.co;2-0

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  APC rearrangements in familial adenomatous polyposis: heterogeneity of deletion lengths and breakpoint sequences underlies similar phenotypes.

Authors:  Marialuisa Quadri; Annalisa Vetro; Viviana Gismondi; Monica Marabelli; Lucio Bertario; Paola Sala; Liliana Varesco; Orsetta Zuffardi; Guglielmina N Ranzani
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

2.  Interstitial Deletion of 5q22.2q23.1 Including APC and TSSK1B in a Patient with Adenomatous Polyposis and Asthenoteratozoospermia.

Authors:  Tanya Kadiyska; Ivan Tourtourikov; Asen Petrov; Ani Chavoushian; Miglena Antalavicheva; Eva-Maria König; Eva Klopocki; Nikolova Vessela; Romil Stanislavov
Journal:  Mol Syndromol       Date:  2018-08-22

Review 3.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors:  Edward David Esplin; Michael Paul Snyder
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Profuse familial adenomatous polyposis with an adenomatous polyposis coli exon 3 mutation.

Authors:  S Nasioulas; I T Jones; D J St John; R J Scott; S M Forrest; R J McKinlay Gardner
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

6.  American founder mutation for attenuated familial adenomatous polyposis.

Authors:  Deborah W Neklason; Jeffery Stevens; Kenneth M Boucher; Richard A Kerber; Nori Matsunami; Jahn Barlow; Geraldine Mineau; Mark F Leppert; Randall W Burt
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12-11       Impact factor: 11.382

7.  Shared genomic segment analysis: the power to find rare disease variants.

Authors:  Stacey Knight; Ryan P Abo; Haley J Abel; Deborah W Neklason; Therese M Tuohy; Randall W Burt; Alun Thomas; Nicola J Camp
Journal:  Ann Hum Genet       Date:  2012-09-19       Impact factor: 1.670

8.  Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer.

Authors:  A Figer; L Irmin; R Geva; D Flex; A Sulkes; E Friedman
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

9.  A novel large germ line deletion in adenomatous polyposis coli (APC) gene associated with familial adenomatous polyposis.

Authors:  Farzaneh Pouya; Afsaneh Mojtabanezhad Shariatpanahi; Kamran Ghaffarzadegan; Seyed Abbas Tabatabaee Yazdi; Hamed Golmohammadzadeh; Ghodratollah Soltani; Kian Aminian Toosi; Mohammad Amin Kerachian
Journal:  Mol Genet Genomic Med       Date:  2018-09-26       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.